title: Erythroid variant of chronic myelogenous leukemia.
authors.forename: N
authors.initials: N
authors.lastname: Talreja
authors.forename: H
authors.initials: H
authors.lastname: Abdulhaq
authors.forename: R K
authors.initials: RK
authors.lastname: Shadduck
authors.forename: J
authors.initials: J
authors.lastname: Rossetti
authors.forename: A
authors.initials: A
authors.lastname: Jalil
authors.forename: A
authors.initials: A
authors.lastname: Makary
authors.forename: J
authors.initials: J
authors.lastname: Lister
mesh_terms: D000328:Adult; D001549:Benzamides; D003937:Diagnosis, Differential; D016044:Fusion Proteins, bcr-abl; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012074:Remission Induction; D013921:Thrombocytopenia / Q000175:diagnosis*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl